MétaCan
Menu
Back to cohort
Record W2746368344 · doi:10.1016/j.jalz.2007.04.048

O2–01–05: Ex vivo molecular imaging in transgenic mouse models of Alzheimer's disease

2007· article· en· W2746368344 on OpenAlexaff
M. Mallar Chakravarty, D. Louis Collins, Simone P. Zehntner, Kurt Hemmings, Christopher Chan, Alex Zijdenbos, Édith Hamel, Alan C. Evans, Barry J. Bedell

Bibliographic record

VenueAlzheimer s & Dementia · 2007
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCell Image Analysis Techniques
Canadian institutionsNeuroRx Research (Canada)Montreal Neurological Institute and Hospital
Fundersnot available
KeywordsEx vivoGenetically modified mouseIn vivoGliosisTransgenePathologyImmunohistochemistryMolecular imagingAmyloid (mycology)Alzheimer's diseaseNeuroscienceBiologyMedicineDiseaseBiochemistry

Abstract

fetched live from OpenAlex

The recent upsurge in the development of novel disease-modifying therapeutic agents for the treatment of Alzheimer's disease (AD) requires efficient and robust methods of determining pre-clinical therapeutic efficacy in transgenic mouse models. While measuring the effects of therapy on AD-type pathological changes on post-mortem tissue remains the gold-standard, conventional methods of evaluation are time-consuming, operator-biased, and limited to specific regions-of-interest. The objective is to develop and evaluate a state-of-the-art technology platform called “ex vivo molecular imaging” which allows for fully-automated, whole-brain, quantitative analysis of AD-type pathology in transgenic mice. The technology platform consists of four major components, (1) specialized preparation and ultra-high resolution digitization of whole-brain histology and immunohistochemistry (IHC) sections, (2) analysis ex-vivo data at the cellular level to generate of quantitative 2D “ex vivo molecular images”, (3) 3D reconstruction of serial 2D images for 3D quantitative maps, and (4) generation of population averages in stereotaxic space and anatomical structure-based statistical analysis of 3D data. For evaluation of this new technique, ex vivo molecular imaging volumes were produced using brains from transgenic AD mice and wild-type littermates, as well as from treated and control mice. Ex vivo molecular imaging volumes demonstrating β-amyloid burden, gliosis, and neuronal density were produced from each mouse brain. Figure 1 depicts a typical coronal view of a β-amyloid ex vivo molecular image from a 16 month-old APP transgenic mouse. Our analyses show significant regional differences between transgenic and wild-type mice, and clearly demonstrates the efficacy of the therapeutic agents evaluated. Conclusions:Ex vivo molecular imaging is a novel strategy for rapid, high-throughput analysis of the natural evolution of AD-type pathology and assessment of the therapeutic efficacy of disease-modifying agents in transgenic mice. The image processing and analysis components are fully-automated, while our specialized techniques for preparation of histology and IHC sections are as automated as possible to maximize efficiency and minimize operator-related variability. We believe that the seamless integration of ex vivo molecular imaging data with non-invasive, in vivo imaging measures of structure and function will, ultimately, allow for a comprehensive analysis of AD in animal models.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.296
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.267
Teacher spread0.255 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2007
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicCell Image Analysis TechniquesFrench-language works237,207